Search Results for: CRBP
Corbus Pharmaceuticals shares skyrocketed on Monday morning after the company announced positive results from its mid-stage clinical trial in systemic sclerosis.
Published:
Last Updated:
Robinhood has become the dominant discount brokerage platform over the last year. It had 4.3 million average revenue trades in June, which is a critical metric in the industry. This is higher than...
Published:
Over the past week, a few pharmaceutical companies made absolutely massive runs.
Published:
Ahead of the California legalization efforts, a U.S.-listed marijuana-focused exchange traded fund has quietly begun trading.
Published:
Last Updated:
Earnings season is winding down but we've found a couple of off-the-radar stocks that are reporting Friday and early Monday.
Published:
Some companies Robinhood traders find most attractive are very risky bets. A hit to the financials of one of these companies or a piece of bad news could easily trigger an extreme sell-off of the...
Published:
If the momentum in biotech can continue, then companies with catalysts within the next 12 to 18 months could get an added boost with any good news.
Published:
Last Updated:
Biotech gets a lot of sustained attention, but some stocks still fall through the cracks, either due to recent failures or general lack of interest.
Published:
Last Updated:
As January wound to a close, beneficial owners, executives, and other insiders took advantage of public offerings of stock at these biotech companies.
Published:
We screened our 24/7 Wall St. research database and found five more stocks trading under the $10 level that could provide investors with some solid upside potential.
Published:
Last Updated:
Another huge Warren Buffett purchase highlighted the past week's insider buying, and a couple of IPOs also prompted insiders to action.
Published:
Warren Buffett boosts his stake in this tracking stock again, plus notable insider buying of communication and aviation stocks in the past week.
Published:
The impact of cannabis products is expected to grow to an estimated $44 billion by 2020. Which companies will be earning those billions?
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday included Bed Bath & Beyond, Celgene, Dow, Fannie Mae, Intel, Lennar, Snap, UGI, Viacom and WEX.
Published:
Last Updated: